Executive leadership across specialized business entities operating under the Genesis Group name comprises seasoned corporate administrators guiding respective real estate, financial, or technology sectors. For specialized biotechnology entities like Genesis Therapeutics, leadership is spearheaded by Dr. Evan Feinberg, who serves as Co-Founder and Chief Executive Officer, directing advanced artificial intelligence platforms for small molecule drug discovery and forging strategic biopharmaceutical partnerships worldwide.